Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07144475Phase 4Completed
Phase 4, randomised, open-label trial (2 arms), sponsored by Dharmais Cancer Hospital. Primary endpoints: Gastrointestinal Function, Sepsis Incidence and 3 more. Started Jan 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07144475.